title: Intraoperative coronary thrombosis: can aprotinin and protamine be incriminated?
authors.affiliation: Department of Anesthesiology, Flemish Free University of Brussels Medical School, Belgium.
authors.forename: V
authors.initials: V
authors.lastname: Umbrain
authors.forename: F
authors.initials: F
authors.lastname: Christiaens
authors.forename: F
authors.initials: F
authors.lastname: Camu
mesh_terms: D000368:Aged; D007611:Aprotinin / Q000009:adverse effects*; D001777:Blood Coagulation / Q000187:drug effects; D001794:Blood Pressure; D002315:Cardiopulmonary Bypass; D003328:Coronary Thrombosis / Q000139:chemically induced*; D017809:Fatal Outcome; D005260:Female; D006083:Graft Occlusion, Vascular / Q000139:chemically induced*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007431:Intraoperative Complications / Q000139:chemically induced*; D008297:Male; D011479:Protamines / Q000009:adverse effects*; D012307:Risk Factors; D014914:Whole Blood Coagulation Time
chemical_list: D011479:Protamines; D006493:Heparin; D007611:Aprotinin